Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;15(8):865-868.
doi: 10.1002/alr.23591. Epub 2025 May 15.

Abridging the 22-Item Sino-Nasal Outcome Test (SNOT-22) in People With Cystic Fibrosis: Limiting Survey Burden

Affiliations

Abridging the 22-Item Sino-Nasal Outcome Test (SNOT-22) in People With Cystic Fibrosis: Limiting Survey Burden

Haidee Chen et al. Int Forum Allergy Rhinol. 2025 Aug.
No abstract available

Keywords: SNOT‐22; chronic rhinosinusitis; disease severity; olfaction; olfactory disorders; olfactory test; quality of life.

PubMed Disclaimer

Conflict of interest statement

Daniel M. Beswick: In the last 36 months. Daniel M. Beswick has received grant support from NIH/NHLBI, CF Foundation, International Society of Inflammation and Allergy of the Nose and the American Rhinologic Society CORE/Sue Ann and John L. Weinberg Foundation; honoraria from sources including from National Jewish Health; consulting fees from Amgen, on medicolegal cases and from Garner Health (equity).

Jeremiah A. Alt: Consultant for OptiNose and Medtronic. Speaker panel GSK. GlycoMira board and equity holder. Kristine A. Smith: In the last 24 months, served as consultant for SanofiGenzyme.

Zachary M. Soler: Consultant for OptiNose, Regeneron, and Lyra; Medical Directory for Healthy Humming. Rodney J. Schlosser: Consultant for OptiNose, Medtronic, Stryker, Cyrano; Medical Directory for Healthy Humming. Jennifer L. Taylor‐Cousar: In the last 36 months, JLT‐C has received grants from the CF Foundation related to this work as well as for work unrelated to the manuscript. Unrelated to this work, she has received grants for her institution from Vertex Pharmaceuticals Incorporated, Eloxx, and 4DMT; received fees from Vertex Pharmaceuticals Incorporated related to consultation on clinical research design, participation on advisory boards, and speaking engagements; and served on advisory boards and/or provided clinical trial design consultation for Insmed, 4DMT, and AbbVie. She serves on a DMC for AbbVie. She serves as the adult patient care representative to the CFF Board of Trustees, and on the CF Foundation's Clinical Research Executive Committee, Clinical Research Advisory Board, Racial Justice Working Group and as immediate past chair of the CF TDN's Sexual Health, Reproduction and Gender Research Working Group, on the scientific advisory board for Emily's Entourage, and on the ATS Respiratory Health Awards, Scientific Grant Review and Clinical Problems Assembly Programming Committees. All other authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
(A and B) Item‐based information of SNOT‐22 items categorized into subdomains with percentage of total information. (A) The horizontal axis represents the percentage of total information in a subdomain. The vertical orange line represents the cut‐off percentage for “above‐average” information, calculated by 100%/number of items in a subdomain. Items with “above‐average” information were retained in the abbreviated surveys. The darker bar in each graph indicates information of all PwCF, while the lighter bar indicates that of PwCF with history of modulator therapy use. (B) The horizontal axis represents the percentage of total information in a subdomain. The six‐ to seven‐item surveys retained the fewest items that encompassed at least 30% of the test information of that subdomain. The darker bar in each graph indicates information of all PwCF, while the lighter bar indicates that of PwCF with history of modulator therapy use.

References

    1. Blount A., Zhang S., Chestnut M., et al., “Transepithelial Ion Transport Is Suppressed in Hypoxic Sinonasal Epithelium,” Laryngoscope 121, no. 9 (2011): 1929–1934, 10.1002/lary.21921. - DOI - PMC - PubMed
    1. Reeve B. B., An Introduction to Modern Measurement Theory (National Cancer Institute, 2002).
    1. Embretson S. E., “The New Rules of Measurement,” Psychological Assessment 8, no. 4 (1996): 341–349, 10.1037/1040-3590.8.4.341. - DOI
    1. Hambleton R. K. and Jones R. W., “Comparison of Classical Test Theory and Item Response Theory and Their Applications to Test Development,” Educational Measurement: Issues and Practice 12, no. 3 (1993): 38–47.
    1. Liu D. T., Phillips K. M., Speth M. M., Besser G., Mueller C. A., and Sedaghat A. R., “Exploring Possibilities for Shortening the 22‐Item Sino‐Nasal Outcome Test (SNOT‐22) Using Item Response Theory,” International Forum of Allergy & Rhinology 12, no. 2 (2022): 191–199, 10.1002/alr.22878. - DOI - PubMed

LinkOut - more resources